Thyroid cancer differentiated · 1 regimen
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Axitinib monotherapy Variant #01 | — | R 21 402 | 28d | ~9.2 mo | ~20.9 mo | ~11 | ~R 235 420 PFS proxy · indirect | 4 |
1 of 1 regimen shown